abstract |
A SHP2 phosphatase allosteric inhibitor having a structure represented by the following formula (I) and a drug containing the inhibitor, and an optical isomer compound of the SHP2 phosphatase allosteric inhibitor in the preparation of a drug for the treatment of a tumor disease or a pharmaceutically acceptable salt thereof. [Formula I] |